Get the Stockscreener App
251.38
0.05%
0.13
After Hours:
251.38
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $251.38, with a volume of 446.72K.
It is up +0.05% in the last 24 hours and up +8.85% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$251.25
Open:
$246.8
24h Volume:
446.72K
Relative Volume:
0.51
Market Cap:
$18.10B
Revenue:
$2.96B
Net Income/Loss:
$487.70M
P/E Ratio:
37.66
EPS:
6.6758
Net Cash Flow:
$344.00M
1W Performance:
+2.45%
1M Performance:
+8.85%
6M Performance:
+0.98%
1Y Performance:
+10.23%
1-Day Range:
$244.91
$251.86
1-Week Range:
$244.83
$254.40
52-Week Range:
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
251.38 | 18.10B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
497.42 | 176.23B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
174.21 | 50.22B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.08 | 41.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.28 | 37.50B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.39 | 37.20B | 27.43B | 1.27B | 1.01B | 1.5829 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Champlain Investment Partners LLC Boosts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services : 2025 Annual Report (2490a2) - marketscreener.com
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. Announces Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical Services, Inc. $WST Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
APG Asset Management N.V. Sells 244,966 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price? - Yahoo Finance
West Pharmaceutical Services Inc (MIL:1WST) Stock Price, Trades & News - GuruFocus
Findlay Park Partners LLP Has $210.42 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Watch West Pharmaceutical’s March investor conference talks online - Stock Titan
Citigroup Inc. Has $21.71 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Declares Dividend, Authorizes $1B Buyback - MyChesCo
TD Asset Management Inc Has $159.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services: Demand Is Outrunning Supply—Can Capacity Investments Close the Gap? - Smartkarma
Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term - sharewise.com
West Pharmaceutical Services promotes COPHEX Korea presence - Traders Union
JPMorgan Chase & Co. Grows Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
How Investors Are Reacting To West Pharmaceutical Services (WST) New US$1 Billion Buyback And Dividend - Sahm
Aug Highlights: Will West Pharmaceutical Services Inc outperform small cap indexesFed Meeting & Long Hold Capital Preservation Tips - baoquankhu1.vn
Deadline Soon: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact The Law - EIN News
Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds - Finviz
Generation Investment Management LLP Sells 189,763 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure - Bitget
West Pharmaceutical (WST) SVP converts RSUs and withholds shares for taxes - Stock Titan
West Pharmaceutical (NYSE: WST) officer converts RSUs and withholds shares for taxes - Stock Titan
West Pharmaceutical Services connects with experts at BIO China event - Traders Union
Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 32.33%: Read This Before Placing a Bet - Finviz
Weekly Earnings: How sensitive is West Pharmaceutical Services Inc to inflation2025 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn
How sensitive is West Pharmaceutical Services Inc. to inflationGold Moves & Weekly Breakout Watchlists - mfd.ru
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Insider Monkey
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? - Yahoo Finance
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability - The Globe and Mail
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWO - GuruFocus
West Pharmaceutical (NYSE: WST) HR leader reports stock grants and tax trades - Stock Titan
Risk Recap: What’s the outlook for West Pharmaceutical Services Inc.’s sectorWeekly Trend Recap & AI Enhanced Market Trend Forecasts - mfd.ru
Pharmaceutical Packaging Market Trends and Growth - GlobeNewswire
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players - Yahoo Finance UK
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings - MyChesCo
5 Insightful Analyst Questions From West Pharmaceutical Services's Q4 Earnings Call - Finviz
West Pharmaceutical (WST) SVP converts RSUs, withholds shares for taxes - Stock Titan
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call - TradingView
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Galapagos (GLPG) and West Pharmaceutical Services (WST) - The Globe and Mail
West Pharmaceutical Services, Inc. (NYSE:WST) Declares $0.22 Quarterly Dividend - MarketBeat
Assetmark Inc. Sells 26,486 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):